Six pioneers artistically celebrated by the Andalusian Society of Nuclear Medicine Poul F. Høilund-CarlsenSalomé Sanz-Viedma Editorial 10 July 2020 Pages: 329 - 331
Clinical translation and implementation of optical imaging agents for precision image-guided cancer surgery F. B. AchterbergM. M. DekenA. L. Vahrmeijer Original Article Open access 12 August 2020 Pages: 332 - 339
Machine learning-based analysis of [18F]DCFPyL PET radiomics for risk stratification in primary prostate cancer Matthijs C. F. CysouwBernard H. E. JansenRonald Boellaard Original Article Open access 31 July 2020 Pages: 340 - 349
Histologic subtype classification of non-small cell lung cancer using PET/CT images Yong HanYuan MaXiuhua Guo Original Article 10 August 2020 Pages: 350 - 360
The deep learning model combining CT image and clinicopathological information for predicting ALK fusion status and response to ALK-TKI therapy in non-small cell lung cancer patients Zhengbo SongTianchi LiuMing Chen Original Article 13 August 2020 Pages: 361 - 371
68Ga-labelled desferrioxamine-B for bacterial infection imaging Milos PetrikEva UmlaufovaClemens Decristoforo Original Article Open access 30 July 2020 Pages: 372 - 382
Development of [89Zr]ZrDFO-amivantamab bispecific to EGFR and c-MET for PET imaging of triple-negative breast cancer Alessandra CavaliereSuxia SunBernadette Marquez-Nostra Original Article 08 August 2020 Pages: 383 - 394
[68Ga]Ga-NODAGA-E[(cRGDyK)]2 PET and hyperpolarized [1-13C] pyruvate MRSI (hyperPET) in canine cancer patients: simultaneous imaging of angiogenesis and the Warburg effect Andreas ClemmensenAdam E HansenAndreas Kjaer Original Article Open access 03 July 2020 Pages: 395 - 405
Myocardial creep-induced misalignment artifacts in PET/MR myocardial perfusion imaging Elia von FeltenGeorgios BenetosRonny R. Buechel Original Article Open access 18 July 2020 Pages: 406 - 413
In vivo quantitative mapping of human mitochondrial cardiac membrane potential: a feasibility study Matthieu Pelletier-GalarneauYoann PetibonNathaniel M. Alpert Original Article 27 July 2020 Pages: 414 - 420
Effects of the COVID-19 pandemic on myocardial perfusion imaging for ischemic heart disease Carmela NappiRosario MegnaAlberto Cuocolo Original Article 11 August 2020 Pages: 421 - 427
The value of 18F-FDG PET/CT for predicting or monitoring immunotherapy response in patients with metastatic melanoma: a systematic review and meta-analysis Narjess AyatiRamin SadeghiAndrew M. Scott Review Article 29 July 2020 Pages: 428 - 448
Clinical impact of follicular oncocytic (Hürthle cell) carcinoma in comparison with corresponding classical follicular thyroid carcinoma Vera WenterNathalie L. AlbertAndrei Todica Original Article Open access 18 July 2020 Pages: 449 - 460
Thyroglobulin doubling time offers a better threshold than thyroglobulin level for selecting optimal candidates to undergo localizing [18F]FDG PET/CT in non-iodine avid differentiated thyroid carcinoma Domenico AlbanoMark TulchinskyRaffaele Giubbini Original Article Open access 13 August 2020 Pages: 461 - 468
Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer Stefano FantiKarolien GoffinAnders Bjartell Original Article Open access 02 July 2020 Pages: 469 - 476
68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer Matthew J. RobertsAndrew MortonJohn Yaxley Short Communication 22 July 2020 Pages: 477 - 482
68Ga-PSMA PET/CT targeted biopsy for the diagnosis of clinically significant prostate cancer compared with transrectal ultrasound guided biopsy: a prospective randomized single-centre study Le-Le ZhangWen-Cheng LiHong-Bin Sun Original Article Open access 30 July 2020 Pages: 483 - 492
PSMA whole-body tumor burden in primary staging and biochemical recurrence of prostate cancer Allan SantosAline MattiolliElba Etchebehere Original Article 13 August 2020 Pages: 493 - 500
False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trial Wolfgang P. FendlerJeremie CalaisThomas A. Hope Short Communication Open access 17 August 2020 Pages: 501 - 508
Pelvic lymph-node staging with 18F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer - the SALT trial - B. H. E. JansenY. J. L. BodarA. N. Vis Original Article Open access 12 August 2020 Pages: 509 - 520
18F-DCFPyL PET/CT for primary staging in 160 high-risk prostate cancer patients; metastasis detection rate, influence on clinical management and preliminary results of treatment efficacy M. WondergemF. M. van der ZantR. J. J. Knol Original Article 27 July 2020 Pages: 521 - 531
Tumour blood flow for prediction of human prostate cancer aggressiveness: a study with Rubidium-82 PET, MRI and Na+/K+-ATPase-density Mads Ryø JochumsenJens SörensenLars Poulsen Tolbod Original Article Open access 18 August 2020 Pages: 532 - 542
Almost 10 years of PET/MR attenuation correction: the effect on lesion quantification with PSMA: clinical evaluation on 200 prostate cancer patients Borjana BogdanovicAndrei GafitaStephan G. Nekolla Original Article Open access 28 July 2020 Pages: 543 - 553
The role of 18F-FAZA PET/CT in detecting lymph node metastases in renal cell carcinoma patients: a prospective pilot trial Umberto CapitanioGino PepeFrancesco Montorsi Original Article 08 July 2020 Pages: 554 - 560
Comprehensive evaluation of 68Ga-PSMA-11 PET/CT parameters for discriminating pathological characteristics in primary clear-cell renal cell carcinoma Jie GaoQinfeng XuHongqian Guo Original Article 04 July 2020 Pages: 561 - 569
2-[18F]FDG PET/CT parameters associated with WHO/ISUP grade in clear cell renal cell carcinoma Yanyan ZhaoCaixia WuZhanli Fu Original Article 19 August 2020 Pages: 570 - 579
Correlation of Y90-absorbed radiation dose to pathological necrosis in hepatocellular carcinoma: confirmatory multicenter analysis in 45 explants Ahmed GabrAhsun RiazRiad Salem Short Communication 04 August 2020 Pages: 580 - 583
Hybrid PET/MRI in non-small cell lung cancer (NSCLC) and lung nodules—a literature review Sara E. Dahlsgaard-WalleniusMalene Grubbe HildebrandtThomas Lund Andersen Review Article 27 July 2020 Pages: 584 - 591
18F-FDG brain PET hypometabolism in post-SARS-CoV-2 infection: substrate for persistent/delayed disorders? E GuedjM MillionD Raoult Short Communication 30 July 2020 Pages: 592 - 595
Clinical validation of the novel HDAC6 radiotracer [18F]EKZ-001 in the human brain Michel KooleDonatienne Van WeehaegheTonya M. Gilbert Original Article Open access 08 July 2020 Pages: 596 - 611
Clinical impact of 18F-FDG-PET among memory clinic patients with uncertain diagnosis Giulia PeriniElena Rodriguez-VieitezAgneta Nordberg Original Article Open access 31 July 2020 Pages: 612 - 622
A critical review of radiotracers in the positron emission tomography imaging of traumatic brain injury: FDG, tau, and amyloid imaging in mild traumatic brain injury and chronic traumatic encephalopathy Cyrus AyubchaMona-Elisabeth RevheimAbass Alavi Review Article 21 July 2020 Pages: 623 - 641
Aggressive Langerhans cell histiocytosis transformation of T cell acute lymphoblastic leukemia detected on 18F-FDG PET/CT Jianjie WangTianbin SongJie Lu Image of the Month 06 June 2020 Pages: 642 - 643
PET/CT with [68Ga]gallium-oxine-labeled heat-denatured red blood cells for detection of dystopic splenic tissue Martin FreesmeyerSebastian GröberRobert Drescher Image of the Month Open access 15 June 2020 Pages: 644 - 646
68Ga-NOTA-FAPI-04 PET/CT in a patient with primary gastric diffuse large B cell lymphoma: comparisons with [18F] FDG PET/CT Guochang WangXiao JinXuejuan Wang Image of the Month 06 July 2020 Pages: 647 - 648
18F-FDG PET/CT findings in a rare monomorphic epitheliotropic intestinal T cell lymphoma Chongjiao LiYong He Image of the Month 06 July 2020 Pages: 649 - 650
[18F]FDG and [68Ga]Ga-DOTA-FAPI-04 PET/CT in the evaluation of tuberculous lesions Bing HaoXiurong WuHaojun Chen Image of the Month 08 July 2020 Pages: 651 - 652
Incidental finding of COVID-19 infection after [68Ga]Ga-PSMA-11 PET/CT imaging in a patient with prostate cancer Camila Edith Stachera StasiakFabrícius Rocha CardosoPaulo Henrique Rosado-de-Castro Image of the Month 24 July 2020 Pages: 653 - 654
Correction to: 68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer Matthew J. RobertsAndrew MortonJohn Yaxley Correction 12 September 2020 Pages: 655 - 656